...
首页> 外文期刊>Virchows Archiv: an international journal of pathology >End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.
【24h】

End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.

机译:终末期肾脏疾病:非肿瘤组织中7号和17号染色​​体的获得和Y染色体的丧失。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to determine the copy number changes of chromosomes 7, 17, 3p, and Y in a non-neoplastic tubular epithelium in end-stage kidney disease (ESKD). Seventeen kidneys from 11 patients with ESKD were retrieved from the archive files. Non-neoplastic kidney tissue in these cases was examined separately. Tissues containing papillary adenomas (PA), clear (CRCC) and papillary renal cell carcinomas (PRCC), and myxoid liposarcoma (LPS) were examined using the same probes and compared with non-neoplastic tissue. Tubular changes in the kidney parenchyma were classified into three types: (1) The vast majority of tubules were entirely atrophic; (2) Several tubules were hyperplastic, i.e., tubules with undifferentiated large epithelial cells, in which it was impossible to establish the specific type of a renal tubulus; (3) Dysplastic tubules were dilated, sometimes wrinkled. The basal membranes were lined by large eosinophilic epithelial cells with polymorphic nuclei and pseudostratification. Nucleoli were clearly visible. These tubular changes were multifocal with a haphazard distribution within the atrophic parenchyma. PA were detected in nine patients, of whom eight patients also revealed an additional tumor type(s) (4x CRCC, 3x PRCC, 1x PRCC, and CRCC). One patient had a CRCC only, another had a combination of PRCC and LPS. Chromosomal abnormalities were found in the second and third group of tubular changes, i.e., in hyperplastic and dysplastic tubules. Trisomy of chromosome 7 was detected in six cases, whereas trisomy of chromosome 17 in eight cases. A combination of both trisomies was found in five cases. Loss of chromosome Y was found in two cases. Fluorescence in situ hybridization on tissues containing papillary adenomas, renal cell carcinomas, and liposarcoma revealed expected results, i.e., trisomy of chromosomes 7 and 17 in all PAs and PRCC. No gains were present in CRCC and LPS. Loss of Y was found in six PA, five PRCC, and one LPS; loss of X was found in two CRCCs. We suggest that chromosomal changes typical of the papillary renal cell lesions, i.e., trisomies of chromosomes 7 and 17, are very frequent in non-neoplastic parenchyma of the end-stage kidney, and they have a tendency to a multifocal occurrence.
机译:这项研究的目的是确定终末期肾脏病(ESKD)的非肿瘤性管状上皮中7、17、3p和Y染色体的拷贝数变化。从档案文件中检索了11名ESKD患者的17个肾脏。在这些情况下,非肿瘤性肾组织需要单独检查。使用相同的探针检查包含乳头状腺瘤(PA),透明(CRCC)和乳头状肾细胞癌(PRCC)以及粘液样脂肪肉瘤(LPS)的组织,并将其与非肿瘤组织进行比较。肾实质的肾小管改变分为三种类型:(1)绝大多数肾小管完全萎缩; (2)一些肾小管是增生性的,即具有未分化的大上皮细胞的肾小管,在其中无法确定特定类型的肾小管; (3)增生小管扩张,有时起皱。基底膜被嗜酸性上皮大细胞衬里,具有多态核和假分层。核仁清晰可见。这些肾小管变化是多灶性的,在萎缩性实质内呈随机分布。在9位患者中检测到PA,其中8位患者还显示出其他肿瘤类型(4x CRCC,3x PRCC,1x PRCC和CRCC)。一名患者只有CRCC,另一名患有PRCC和LPS。在第二和第三组肾小管改变中,即在增生和增生的肾小管中发现了染色体异常。 6例检测到7号染色体的三体性,而8例检测到17号染色​​体的三体性。在五例中发现了两个三体症的组合。有2例发现Y染色体丢失。在包含乳头状腺瘤,肾细胞癌和脂肪肉瘤的组织上进行荧光原位杂交显示了预期的结果,即在所有PA和PRCC中染色体7和17的三体性。 CRCC和LPS没有收益。在6个PA,5个PRCC和1个LPS中发现Y丢失; X在两个CRCC中丢失。我们建议在末期肾脏的非肿瘤实质中,乳头状肾细胞病变的典型染色体变化(即7号和17号染色​​体的三体性)非常频繁,并且它们倾向于多灶发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号